defin
eight
antigen
group
ah
group
rv
caus
human
infect
outer
capsid
protein
elicit
neutral
antibodi
determin
serotyp
respect
design
g
glycoprotein
p
proteasesensit
protein
nowaday
serotyp
larg
replac
genotyp
rotavirus
design
dual
system
g
p
letter
follow
number
notat
serotyp
second
number
bracket
p
genotyp
frequent
genotypeonli
design
exampl
human
rv
strain
wa
design
least
g
p
genotyp
acut
diarrhea
lead
caus
morbid
second
commonest
caus
mortal
children
age
year
old
worldwid
estim
age
group
billion
case
million
sever
episod
death
older
children
adolesc
adult
estim
billion
case
diarrhea
per
year
virus
account
acut
diarrhea
ill
describ
bishop
et
al
human
rotavirus
rv
repres
main
agent
acut
gastroenter
infant
young
children
worldwid
rotavirus
rv
belong
famili
reovirida
intact
nm
particl
triplelay
structur
core
inner
outer
capsid
layer
core
enclos
viral
genom
consist
segment
doublestrand
rna
segment
encod
one
protein
except
segment
encod
two
figur
tabl
six
protein
form
virion
structur
core
made
major
constitu
sole
compon
inner
capsid
outer
capsid
compos
form
capsom
spikelik
structur
radiat
inner
outer
capsid
give
viru
characterist
wheellik
appear
rota
wheel
addit
six
nonstructur
protein
express
infect
cell
particip
replic
cycl
key
concept
acut
diarrhea
lead
caus
morbid
second
commonest
caus
mortal
children
year
old
worldwid
acut
diarrheal
ill
caus
virus
norovirus
commonest
caus
diarrhea
age
group
combin
rotavirus
still
lead
caus
diarrhea
children
year
old
transmiss
mainli
fecalor
rout
persontoperson
contact
contamin
food
water
case
viral
diarrhea
mild
selflimit
sever
case
occur
lead
dehydr
death
repeat
episod
lead
malnutrit
case
manag
home
oral
rehydr
solut
feed
regular
diet
vaccin
best
prevent
measur
rotaviru
vaccin
avail
breastfeed
vitamin
supplement
zinc
significantli
reduc
frequenc
andor
sever
diarrhea
usual
clinic
characterist
gastroenter
viru
infect
matur
particl
play
key
role
assembl
process
particl
ca
depend
lastli
matur
virus
releas
cell
lysi
vesicular
transport
infect
intestin
cell
chang
columnar
cuboid
fewer
shorter
microvilli
cell
slough
result
shorter
villi
chang
occur
within
hour
infect
start
proxim
progress
caudal
diarrhea
result
mixtur
caus
decreas
absorpt
salt
water
secondari
enterocyt
damag
replac
absorpt
intestin
cell
secret
cell
crypt
loss
disaccharid
damag
brush
border
tabl
nov
sav
produc
diarrheal
ill
human
nov
lead
caus
acut
gastroenter
worldwid
cv
genom
kilobas
length
organ
two
three
open
read
frame
orf
genera
three
orf
nov
vesiviru
first
orf
encod
larg
protein
proteolyt
cleavag
produc
nsp
encod
singl
major
structur
protein
encod
minor
structur
protein
neboviru
lagoviru
orf
virus
encod
respect
typic
cv
norwalk
viru
capsid
form
dimer
archlik
protrud
capsom
arrang
way
leav
calic
viral
surfac
two
major
domain
shell
domain
protrud
p
domain
domain
form
inner
part
capsid
amino
acid
aa
includ
aa
correspond
n
termin
region
protein
n
subdomain
face
interior
capsid
p
domain
includ
amino
acid
subdivid
subdomain
subdomain
aa
form
side
capsom
wherea
subdomain
aa
form
protrud
part
capsom
arch
figur
virion
one
two
copi
kda
result
carbohydr
malabsorpt
osmot
diarrhea
effect
viral
enterotoxin
increas
plasma
membran
chlorid
permeabl
lead
secretori
diarrhea
rv
rna
replic
virus
frequent
detect
blood
cerebrospin
fluid
show
rv
repres
system
infect
increas
proinflammatori
cytokin
immun
rv
like
multifactori
involv
local
mucos
system
serum
antibodi
well
innat
cellular
immun
induc
serumneutr
antibodi
infect
serotyp
homotyp
appear
within
week
infect
correl
protect
heterotyp
antibodi
differ
serotyp
also
occur
mainli
among
adult
depend
infect
strain
homotyp
protect
last
longer
heterotyp
protect
incomplet
short
live
antirv
antibodi
level
high
birth
transplacent
acquir
declin
month
rise
peak
year
remain
elev
throughout
life
probabl
repeat
mostli
asymptomat
infect
serum
antibodi
alway
prevent
infect
point
potenti
role
mucos
immun
exampl
iga
defici
mice
shed
rv
prolong
time
protect
reinfect
furthermor
mucos
immun
passiv
acquir
breastfeed
oral
administ
immun
globulin
amelior
rv
symptom
mucos
immun
develop
week
infect
persist
sever
month
eventu
decreas
advanc
age
experiment
clinic
data
suggest
role
nonneutr
antibodi
protect
rv
diseas
cellmedi
immun
also
seem
import
mice
rvspecif
cytotox
cell
appear
intestin
mucosa
soon
infect
mice
sever
combin
immunodefici
abl
clear
rv
infect
reconstitut
cell
despit
lack
antibodi
viru
lastli
role
innat
immun
explor
clinic
spectrum
rv
infect
rang
asymptomat
sever
diseas
dehydr
death
sever
may
associ
antigenemia
usual
clinic
pictur
present
tabl
addit
transaminas
elev
occur
case
neurolog
manifest
increasingli
recogn
diseas
selflimit
chronic
infect
describ
normal
host
neonat
rv
infect
symptomat
case
usual
mild
sever
infect
may
occur
among
prematur
infant
special
care
unit
immunodefici
individu
present
chronic
seriou
cours
associ
mortal
children
human
immunodefici
viru
hiv
infect
receiv
antiretrovir
therapi
may
twofold
risk
rv
symptomat
infect
prolong
viru
shed
sever
ill
may
similar
seen
hivuninfect
children
diagnost
microbiolog
antigen
detect
kit
base
enzym
immunoassay
eia
latex
agglutin
test
choic
clinic
circumst
high
sensit
specif
sampl
obtain
symptomat
period
sampl
process
immedi
store
frozen
seminest
revers
transcript
polymeras
chain
reaction
rtpcr
test
allow
g
p
genotyp
special
situat
test
consid
electron
microscopi
em
gel
electrophoresi
viral
rna
hybrid
radiolabel
nucleic
acid
probe
viral
cultur
serolog
test
rare
use
neutral
antibodi
detect
plaqu
reduct
cytopath
effect
inhibit
kapikian
et
al
investig
gastroenter
outbreak
norwalk
ohio
visual
nm
particl
stool
filtrat
note
norwalk
viruslik
particl
month
year
age
birth
cohort
studi
peru
follow
children
year
respect
year
children
least
one
noroviru
infect
year
one
episod
norovirusassoci
diarrhea
genogroup
ii
strain
produc
major
infect
given
time
infect
caus
major
circul
strain
exampl
gii
genogroup
caus
sporad
infect
children
worldwid
genogroup
strain
caus
us
outbreak
sinc
coinfect
differ
strain
occur
give
opportun
exchang
genet
materi
strain
gener
new
viru
variant
pandem
variant
emerg
everi
year
outbreak
occur
mainli
daycar
center
school
colleg
hospit
nurs
home
militari
barrack
restaur
vacat
facil
cruis
ship
nov
also
caus
travel
diarrhea
nov
spread
intern
contamin
food
beverag
studi
foodborn
outbreak
gastroenter
show
median
affect
person
versu
bacteri
outbreak
ten
percent
individu
requir
medic
care
hospit
sapoviru
epidemiolog
summar
tabl
detect
rate
vari
differ
countri
much
lower
nov
ill
milder
environ
eat
habit
hygien
practic
like
play
role
differ
attack
rate
calicivirus
ubiquit
stabl
environ
provid
persist
sourc
infect
norovirus
surviv
freez
heat
minut
stabl
water
chlorin
mgl
municip
water
system
contain
mgl
chlorin
viru
also
acidresist
etherst
calicivirus
transmit
fecalor
vomitor
rout
sporad
outbreak
case
spread
mainli
persontoperson
contact
patient
contagi
first
day
ill
contamin
food
water
import
caus
outbreak
transmiss
contamin
object
surfac
environ
like
import
may
last
week
longer
inhal
swallow
aerosol
produc
vomit
toilet
flush
may
also
play
role
noroviru
spread
genogroup
taxonomi
calicivirida
famili
function
complet
understood
appear
interact
genom
rna
viru
replic
self
assembl
viruslik
particl
vlp
without
rna
particip
need
vlp
assembl
essenti
infect
felin
caliciviru
vlp
morpholog
antigen
similar
natur
virion
nov
six
nonstructur
protein
differ
function
nsp
replic
complex
format
ntpase
nucleosid
triphosphataserna
helicas
replic
complex
format
vpg
genom
link
protein
involv
translat
replic
pro
proteas
pol
rdrp
rnadepend
rna
polymeras
play
role
replic
process
genom
rna
epidemiolog
human
calicivirus
hucv
worldwid
distribut
nov
infect
person
age
highincom
lowand
middleincom
countri
lmic
common
caus
gastroenter
outbreak
also
recogn
common
caus
endem
gastroenter
usa
nov
produc
emerg
depart
visit
million
offic
visit
per
year
also
account
million
ill
hospit
death
noroviru
commonli
detect
pathogen
adult
gastroenter
studi
children
year
age
acut
gastroenter
rv
nov
detect
case
respect
studi
conclus
noroviru
becom
lead
caus
medic
attend
gastroenter
us
children
respons
approxim
million
healthcar
visit
yearli
noroviru
infect
occur
mainli
cold
season
almost
case
outbreak
occur
octob
march
northern
hemispher
april
septemb
southern
hemispher
reason
season
well
understood
rainfal
may
play
role
break
season
pattern
observ
emerg
new
variant
strain
noroviru
infect
start
earli
life
finnish
studi
found
preval
igg
antibodi
children
age
product
protect
infect
earlier
studi
suggest
immun
mostli
shortterm
year
typespecif
howev
sever
clinic
epidemiolog
observ
inconsist
notion
mathemat
model
commun
transmiss
noroviru
estim
immun
durat
gastroenter
year
human
infecti
dose
genom
equival
median
incub
period
day
patient
develop
symptom
day
symptomat
day
studi
nov
infect
volunt
describ
patholog
chang
proxim
portion
small
intestin
broaden
blunt
villi
crypt
cell
hyperplasia
cytoplasm
vacuol
mononuclear
cell
infiltr
lamina
propria
brush
border
enzym
decreas
produc
malabsorpt
carbohydr
fat
chang
transient
resolv
within
week
histolog
lesion
seen
gastric
rectal
mucosa
secret
hydrochlor
acid
pepsin
intrins
factor
remain
normal
gastric
empti
markedli
delay
could
explain
frequenc
nausea
vomit
howev
degre
delay
correl
sever
vomit
reduct
villou
surfac
area
seal
junction
protein
well
increas
activ
anion
secret
cytotox
intraepitheli
lymphocyt
apoptosi
observ
suggest
noroviru
diarrhea
caus
leak
flux
secretori
compon
viru
shed
stool
begin
prodrom
stage
last
day
median
day
persist
sever
week
resolut
symptom
especi
infant
month
year
immunocompromis
patient
noroviru
infect
start
protrud
domain
p
bind
specif
carbohydr
receptor
cell
membran
thereaft
nov
enter
cell
process
requir
protein
receptor
follow
viru
uncoat
releas
vpglink
rna
genom
cytoplasm
genom
replic
start
negativesens
rna
intermedi
process
perform
rdrp
genom
function
mrna
first
viral
rna
translat
becom
templat
doublestrand
replic
form
rf
thereaft
positivesens
rna
synthesi
begin
replic
process
full
genom
subgenom
rna
form
subgenom
rna
consist
last
kb
genom
also
attach
vpg
gener
polyprotein
cleavag
produc
nsp
recruit
cellular
membran
form
replic
complex
capsid
protein
translat
mainli
subgenom
rna
selfassembl
form
capsid
vlp
nevertheless
requir
infect
mechan
viral
assembl
releas
virion
poorli
understood
apoptosi
propos
exit
strategi
assum
hunov
replic
occur
epitheli
cell
upper
gastrointestin
tract
howev
viral
particl
observ
em
jejunum
mucosa
figur
suscept
nv
peculiar
individu
natur
resist
infect
lack
viru
receptor
repeat
challeng
viru
fail
produc
ill
antibodi
respons
noroviru
receptor
histoblood
group
antigen
hbga
hbga
complex
carbohydr
present
surfac
erythrocyt
enterocyt
mucos
cell
hbga
includ
abo
lewi
secretor
famili
hbga
product
genet
control
gene
control
express
fucosyltransferas
saliva
mucos
secret
individu
gene
call
nonsecretor
twenti
percent
european
nonsecretor
resist
infect
nv
recognit
carbohydr
receptor
common
characterist
caliciviru
differ
cv
differ
carbohydr
receptor
determin
host
tissu
tropism
noroviru
immun
studi
difficult
cell
cultur
system
small
anim
model
human
volunt
natur
infect
studi
demonstr
virusspecif
antibodi
respons
serum
igg
igm
iga
well
mucos
iga
antibodi
produc
cellmedi
immun
induc
vlp
serum
igg
antibodi
persist
month
igm
iga
short
live
mucos
iga
persist
known
antibodi
presenc
alway
correl
protect
howev
earli
day
mucos
iga
pcr
amplif
use
serotyp
determin
serolog
test
rare
use
specif
antibodi
detect
neutral
hemagglutin
inhibit
assay
enter
adenovirus
difficult
grow
routin
cell
line
eg
intestin
other
isol
method
improv
clinic
manifest
enter
adenovirus
present
tabl
gener
diseas
milder
prolong
rv
treatment
support
cidofovir
oral
lipid
conjug
brincidofovir
alon
ribavirin
use
immunocompromis
patient
astrovirus
belong
famili
astrovirida
first
describ
small
nm
particl
fiveor
sixpoint
star
appear
em
later
studi
show
icosahedr
nm
morpholog
welldefin
spike
figur
subject
high
ph
transform
previous
describ
star
viru
nonenvelop
singlestrand
positivesens
rna
genom
contain
three
orf
encod
viral
proteas
polymeras
respect
encod
protein
capsid
precursor
give
rise
structur
capsid
protein
appear
respons
antigen
variat
eight
serotyp
describ
astrovirus
infect
mammal
bird
transmiss
may
zoonot
human
astrovirus
respons
endem
diarrhea
children
worldwid
preval
associ
outbreak
daycar
center
school
pediatr
ward
infect
confer
protect
antibodi
increas
age
adult
antibodi
immunocompromis
subject
elderli
may
also
affect
histopatholog
studi
show
infect
matur
epitheli
cell
small
intestin
without
inflammatori
respons
viru
inactiv
methanol
heat
minut
howev
resist
chloroform
ethanol
diagnosi
made
commerci
immunoassay
good
sensit
specif
compar
em
rtpcr
astrovirus
grown
cell
clinic
characterist
astroviru
infect
present
tabl
symptom
similar
rv
infect
less
sever
manag
support
usual
clinic
characterist
noroviru
sapoviru
infect
present
tabl
time
infect
acut
shortliv
asymptomat
nevertheless
sever
prolong
ill
death
may
occur
sever
outcom
associ
nov
strain
popul
risk
includ
elderli
healthcar
facil
young
infant
immunosuppress
individu
chronic
debilit
condit
usual
present
immedi
caus
death
includ
aspir
pneumonia
sepsi
gastrointestin
bleed
perfor
necrot
enterocol
prefer
method
nov
sav
detect
realtim
revers
transcriptionpcr
rtpcr
sensit
virion
use
clinic
environment
specimen
also
use
quantifi
viral
load
rtqpcr
rtpcr
use
genotyp
center
diseas
control
prevent
cdc
surveil
nov
outbreak
enzym
immunoassay
eia
rapid
use
test
multipl
specimen
outbreak
howev
sensit
neg
sampl
retest
rtpcr
eia
replac
rtpcr
outbreak
investig
eia
use
detect
antibodi
virus
seroepidemiolog
studi
whole
diarrhea
stool
collect
within
hour
ill
test
done
within
week
sampl
kept
refriger
longer
time
sampl
frozen
ship
sampl
seal
separ
plastic
bag
kept
frozen
refriger
pack
insul
waterproof
polystyren
contain
vomitu
sampl
process
way
stool
water
environment
sampl
food
shellfish
sampl
process
cdc
fda
guidanc
respect
enter
adenovirus
first
describ
famili
adenovirida
includ
human
adenovirus
classifi
seven
group
ag
respiratori
adenovirus
two
serotyp
belong
group
f
enter
pathogen
group
adenovirus
may
also
enteropathogen
popul
adenovirus
nonenvelop
virus
dsdna
genom
surround
icosahedr
capsid
fiberlik
project
vertic
tabl
virion
contain
hexon
major
surfac
protein
penton
penton
consist
base
fiber
genusspecif
antigen
locat
hexon
typespecif
antigen
locat
hexon
fiber
elicit
serumneutr
antibodi
fiber
protein
adenovirus
bind
coxsackieadenoviru
receptor
car
epitheli
cell
penton
base
mediat
intern
viru
infect
cell
degener
process
depend
viru
protein
mechan
serotyp
induc
gastroenter
remain
unclear
enter
adenovirus
worldwid
distribut
mainli
affect
young
children
respons
acut
gastroenter
episod
seen
outpati
clinic
seen
hospit
children
outbreak
last
day
occur
hospit
daycar
center
approxim
children
infect
half
asymptomat
transmiss
persontoperson
fecalor
rout
infect
person
develop
groupand
typespecif
antibodi
confer
longterm
immun
stool
excret
adenovirus
last
day
day
day
end
diarrhea
asymptomat
excret
may
last
month
year
thu
isol
diarrheic
stool
necessarili
mean
acut
infect
adenovirus
less
resist
rv
rapidli
inactiv
exposur
ultraviolet
light
formalin
viral
antigen
detect
stool
immunoassay
studi
artifici
formula
supplement
probiot
may
reduc
incid
diarrhea
shorten
rv
shed
practic
effect
intervent
prevent
gastroenter
vaccin
howev
vaccin
avail
rotaviru
first
commerci
rv
vaccin
wyethayerst
laboratori
licens
usa
vaccin
effect
prevent
rv
diarrhea
effect
prevent
sever
rv
diarrhea
suspend
due
associ
intussuscept
estim
one
addit
vaccin
infant
decad
later
two
new
rv
vaccin
licens
live
vaccin
tabl
contain
five
bovinehuman
reassort
strain
four
express
human
bovin
specif
one
express
bovin
human
three
dose
administ
month
age
demonstr
efficaci
prevent
rv
diseas
sever
diseas
second
rv
vaccin
live
monoval
vaccin
tabl
deriv
human
attenu
strain
specif
two
dose
month
prove
effect
prevent
sever
rv
diseas
world
health
organ
recommend
inclus
rv
vaccin
nation
immun
program
america
europ
worldwid
usa
introduc
result
reduct
rvrelat
hospit
emerg
depart
ed
visit
outpati
visit
concomitantli
decreas
allcaus
gastroenter
visit
hospit
benefit
note
even
singl
dose
either
vaccin
includ
heterotyp
protect
herd
immun
also
present
either
vaccin
countri
introduc
rv
vaccin
seen
virtual
disappear
previous
predomin
strain
proport
increas
genotyp
especi
mainli
seen
use
mainli
use
whether
chang
repres
effect
vaccin
pressur
rather
secular
chang
circul
rv
strain
unclear
studi
lmic
africa
asia
show
lower
efficaci
prevent
sever
diseas
vari
case
human
gastroenter
associ
parechovirus
enterovirus
cardiovirus
kubovirus
coronavirus
torovirus
pestivirus
parvovirus
picobirnavirus
other
role
agent
gastroenter
studi
viral
gastroenter
case
mild
moder
sever
selflimit
sever
ill
occur
mainli
young
children
elderli
immunocompromis
patient
specif
antivir
exist
gastroenter
virus
primari
object
manag
prevent
treatment
dehydr
malnutrit
patient
treat
home
oral
rehydr
solut
or
feed
regular
diet
or
may
prevent
diarrheal
death
occasion
hospit
intraven
fluid
may
need
sever
ill
although
lactos
malabsorpt
develop
frequent
acut
gastroenter
children
fed
lactosecontain
formula
small
frequent
feed
human
milk
despit
high
lactos
content
reduc
stool
output
provid
excel
nutrient
antiinfecti
factor
therefor
breastfeed
continu
protect
effect
breastfeed
diarrhea
morbid
mortal
confirm
special
formul
or
resom
less
sodium
potassium
glucos
addit
magnesium
copper
zinc
well
continu
feed
caloriedens
food
recommend
malnourish
patient
readytous
therapeut
food
proven
success
lmic
vitamin
supplement
reduc
allcaus
diarrhea
mortal
children
age
month
zinc
given
day
diarrheal
episod
decreas
diarrhea
mortal
antiemet
usual
unnecessari
singl
dose
ondansetron
reduc
vomit
use
intraven
fluid
length
stay
routin
use
support
cdc
adsorb
kaolin
pectin
antimotil
agent
opiat
loperamid
affect
diarrhea
mechan
may
seriou
side
effect
paralyt
ileu
nitazoxanid
bismuth
subsalicyl
probiot
bovin
colostrum
human
serum
immunoglobulin
tri
patient
sever
ill
modest
effect
develop
specif
antivir
still
earli
stage
prevent
hygien
measur
decreas
persontoperson
spread
howev
measur
difficult
enforc
situat
involv
crowd
young
children
nurs
home
etc
virus
may
surviv
environ
week
resist
commonli
use
disinfect
transmiss
diseas
continu
even
place
good
sanit
outbreak
requir
furlough
ill
personnel
thoroughli
cook
food
disinfect
environ
properli
handl
food
water
sanit
care
hand
wash
overemphas
especi
among
food
handler
personnel
hospit
school
daycar
center
hospit
institution
patient
place
univers
precaut
ad
contact
isol
hour
symptom
resolut
chemic
disinfect
interrupt
viru
spread
environ
special
attent
given
bathroom
door
knob
hand
rail
food
prepar
surfac
commonli
use
disinfect
ethanol
hydrogen
peroxid
ppm
chlorin
povidoneiodin
ultraviolet
radiat
heat
sinc
fecal
matter
inactiv
hypochlorit
remov
applic
household
laundri
wash
deterg
bleach
follow
dri
cycl
heat
least
minut
high
pressur
process
also
use
breastfeed
may
reduc
sever
durat
rv
ill
incid
licens
vaccin
exist
noroviru
vaccin
develop
complic
sever
factor
includ
multipl
viru
type
antigen
variat
inabl
cultur
viru
small
anim
model
partial
understand
immun
effect
previou
infect
nov
vlp
given
oral
mice
human
volunt
safe
induc
iga
antibodi
respons
nov
vlp
vaccin
given
intranas
volunt
reduc
frequenc
gastroenter
subclin
infect
particip
given
norwalk
viru
refer
avail
onlin
expertconsultcom
postlicensur
surveil
detect
risk
intussuscept
mainli
first
dose
estim
addit
infant
vaccin
risk
consid
small
outweigh
benefit
vaccin
countri
pursu
rv
vaccin
advanc
clinic
test
lanzhou
lamb
rv
llr
vaccin
licens
china
sinc
report
effect
rvhospit
rv
diarrhea
respect
india
vaccin
develop
base
natur
humanbovin
rv
reassort
efficaci
prevent
sever
rv
diseas
candid
vaccin
enter
earli
phase
clinic
trial
